Detalles de la búsqueda
1.
Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
N Engl J Med;
389(5): 430-440, 2023 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37530824
2.
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépression.
Can J Psychiatry;
69(7): 493-502, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600892
3.
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.
Can J Psychiatry;
69(3): 183-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796764
4.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.
Can J Psychiatry;
: 7067437241245384, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711351
5.
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.
J Hepatol;
79(4): 888-897, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355043
6.
Enhanced Characterization of Histones Using 193 nm Ultraviolet Photodissociation and Proton Transfer Charge Reduction.
Anal Chem;
95(14): 5985-5993, 2023 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36989418
7.
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report.
Psychol Med;
53(12): 5374-5384, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36004538
8.
Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: a CAN-BIND-1 Study Report.
Cerebellum;
22(1): 26-36, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023065
9.
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report.
CNS Spectr;
28(6): 739-746, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37218291
10.
Baseline Functional Connectivity in Resting State Networks Associated with Depression and Remission Status after 16 Weeks of Pharmacotherapy: A CAN-BIND Report.
Cereb Cortex;
32(6): 1223-1243, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416758
11.
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report.
Can J Psychiatry;
68(8): 586-595, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36785892
12.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Can J Psychiatry;
68(1): 5-21, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975555
13.
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
Can J Psychiatry;
68(5): 299-311, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711159
14.
Smartphone-based interventions in bipolar disorder: Systematic review and meta-analyses of efficacy. A position paper from the International Society for Bipolar Disorders (ISBD) Big Data Task Force.
Bipolar Disord;
24(6): 580-614, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839276
15.
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes.
Pediatr Diabetes;
23(2): 173-182, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779087
16.
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin.
Pediatr Diabetes;
23(2): 183-193, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779103
17.
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study.
Pharmacopsychiatry;
55(6): 297-303, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793696
18.
Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Can J Psychiatry;
67(10): 745-754, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35522196
19.
Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine.
Can J Psychiatry;
67(1): 39-47, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379019
20.
"One Degree of Separation": A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19.
Can J Psychiatry;
67(9): 712-722, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986035